ORI Updates

ORI found that Dr. Sudhakar Yakkanti (Respondent), former staff scientist and Director of the Cell Signaling, Retinal & Tumor Angiogenesis Laboratory, BTNRH, engaged in research misconduct in research supported by PHS funds, specifically, NCI, NIH, NEI, NIH, and NIDDK, NIH.

ORI found that Deepti Malhotra, Ph.D. (Respondent), former Doctoral Student and Postdoctoral Fellow, Department of Environmental Health Sciences, JHSPH, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH).

ORI found that Erin N. Potts Kant engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH).

ORI awarded five Research Integrity Conferences (RIC) grants through the Extramural Research Program, funding a total of $244,796. The RIC grants allows up to $50,000 in direct and indirect funding to support conferences designed to provide a forum for discussion and produce tangible outcomes related to promoting research integrity and preventing research misconduct.

ORI awarded eight Research on Research Integrity projects through the Extramural Research Program, funding a total of $1,135,316. The RRI grants allows up to $150,000 in direct and indirect funding for projects that foster innovative approaches for research on research integrity and preventing misconduct. 

ORI released forecasts for three funding opportunity announcements (FOAs) for research integrity grants, including a new Program Development and Evaluation (PDE) program. ORI will continue to support the Research on Research Integrity (RRI) and the Research Integrity Conferences (RIC) grant programs.

This free workshop will explore issues around conceptions of privacy, ways to protect data confidentiality, and how IRBs and review bodies can learn more about protections and ethical oversight of important research.

Research Misconduct Finding: Rahul Agrawal
ORI found that Dr. Rahul Agrawal, former visiting fellow at the Center for Cancer Research, Laboratory of Pathology, Cancer Molecular Pathology Section, National Cancer Institute (NCI), NIH, engaged in research misconduct in research supported by the Intramural Research Program of NCI, NIH.

Alexander Runko, Ph.D., starting Aug. 4, will be the new Director of ORI’s Division of Investigative Oversight (DIO).

Adm. Brett P. Giroir, M.D., HHS Assistant Secretary for Health, announced today that Elisabeth Handley will join the Office of Research Integrity as the Interim Director.